Differentiation-independent fluctuation of pluripotency-related transcription factors and other epigenetic markers in embryonic stem cell colonies

. 2012 Mar 20 ; 21 (5) : 710-20. [epub] 20110708

Jazyk angličtina Země Spojené státy americké Médium print-electronic

Typ dokumentu časopisecké články, práce podpořená grantem

Perzistentní odkaz   https://www.medvik.cz/link/pmid21609209

Embryonic stem cells (ESCs) maintain their pluripotency through high expression of pluripotency-related genes. Here, we show that differing levels of Oct4, Nanog, and c-myc proteins among the individual cells of mouse ESC (mESC) colonies and fluctuations in these levels do not disturb mESC pluripotency. Cells with strong expression of Oct4 had low levels of Nanog and c-myc proteins and vice versa. In addition, cells with high levels of Nanog tended to occupy interior regions of mESC colonies. In contrast, peripherally positioned cells within colonies had dense H3K27-trimethylation, especially at the nuclear periphery. We also observed distinct levels of endogenous and exogenous Oct4 in particular cell cycle phases. The highest levels of Oct4 occurred in G2 phase, which correlated with the pKi-67 nuclear pattern. Moreover, the Oct4 protein resided on mitotic chromosomes. We suggest that there must be an endogenous mechanism that prevents the induction of spontaneous differentiation, despite fluctuations in protein levels within an mESC colony. Based on the results presented here, it is likely that cells within a colony support each other in the maintenance of pluripotency.

Zobrazit více v PubMed

Brüstle O. Spiro AC. Karram K. Choudhary K. Okabe S. McKay RD. In vitro-generated neural precursors participate in mammalian brain development. Proc Natl Acad Sci USA. 1997;94:14809–14814. PubMed PMC

Wang L. Li L. Shojaei F. Levac K. Cerdan C. Menendez P. Martin T. Rouleau A. Bhatia M. Endothelial and hematopoietic cell fate of human embryonic stem cells originates from primitive endothelium with hemangioblastic properties. Immunity. 2004;21:31–41. PubMed

Klug MG. Soonpaa MH. Koh GY. Field LJ. Genetically selected cardiomyocytes from differentiating embronic stem cells form stable intracardiac grafts. J Clin Invest. 1996;98:216–224. PubMed PMC

Levenberg S. Golub JS. Amit M. Itskovitz-Eldor J. Langer R. Endothelial cells derived from human embryonic stem cells. Proc Natl Acad Sci USA. 2002;99:4391–4396. PubMed PMC

O'Shea KS. Self-renewal vs. differentiation of mouse embryonic stem cells. Biol Reprod. 2004;71:1755–1765. PubMed

Chambers I. The molecular basis of pluripotency in mouse embryonic stem cells. Cloning Stem Cells. 2004;6:386–391. PubMed

Takahashi K. Yamanaka S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell. 2006;126:663–676. PubMed

Hochedlinger K. Jaenisch R. Nuclear reprogramming and pluripotency. Nature. 2006;441:1061–1067. PubMed

Eminli S. Jaenisch R. Hochedlinger K. Strategies to induce nuclear reprogramming. Ernst Schering Found Symp Proc. 2006;5:83–98. PubMed

Amabile G. Meissner A. Induced pluripotent stem cells: current progress and potential for regenerative medicine. Trends Mol Med. 2009;15:59–68. PubMed

Mikkelsen TS. Hanna J. Zhang X. Ku M. Wernig M. Schorderet P. Bernstein BE. Jaenisch R. Lander ES. Meissner A. Dissecting direct reprogramming through integrative genomic analysis. Nature. 2008;454:49–55. Erratum in 794. PubMed PMC

Jia F. Wilson KD. Sun N. Gupta DM. Huang M. Li Z. Panetta NJ. Chen ZY. Robbins RC, et al. A nonviral minicircle vector for deriving human iPS cells. Nat Methods. 2010;7:197–199. PubMed PMC

Efroni S. Duttagupta R. Cheng J. Dehghani H. Hoeppner DJ. Dash C. Bazett-Jones DP. Le Grice S. McKay RD et al. Global transcription in pluripotent embryonic stem cells. Cell Stem Cell. 2008;2:437–447. PubMed PMC

Krejčí J. Uhlířová R. Galiová G. Kozubek S. Smigová J. Bártová E. Genome-wide reduction in H3K9 acetylation during human embryonic stem cell differentiation. J Cell Physiol. 2009;219:677–687. PubMed

Meshorer E. Misteli T. Chromatin in pluripotent embryonic stem cells and differentiation. Nat Rev Mol Cell Biol. 2006;7:540–546. PubMed

Mattout A. Meshorer E. Chromatin plasticity and genome organization in pluripotent embryonic stem cells. Curr Opin Cell Biol. 2010;22:334–341. PubMed

Veselá I. Kotasová H. Jankovská S. Procházková J. Pacherník J. Leukaemia inhibitory factor inhibits cardiomyogenesis of mouse embryonic stem cells via STAT3 activation. Folia Biol (Prague) 2010;56:165–172. PubMed

Bártová E. Stixová L. Galiová G. Harničarová Horáková A. Legartová S. Kozubek S. Mutant genetic background affects the functional rearrangement and kinetic properties of JMJD2b histone demethylase. J Mol Biol. 2011;405:679–695. PubMed

Harničarová A. Kozubek S. Pacherník J. Krejčí J. Bártová E. Distinct nuclear arrangement of active and inactive c-myc genes in control and differentiated colon carcinoma cells. Exp Cell Res. 2006;312:4019–4035. PubMed

Bártová E. Krejčí J. Harničarová A. Kozubek S. Differentiation of human embryonic stem cells induces condensation of chromosome territories and formation of heterochromatin protein 1 foci. Differentiation. 2008a;76:24–32. PubMed

Bártová E. Galiová G. Krejčí J. Harničarová A. Strašák L. Kozubek S. Epigenome and chromatin structure in human embryonic stem cells undergoing differentiation. Dev Dyn. 2008b;237:3690–3702. PubMed

Schoeftner S. Sengupta AK. Kubicek S. Mechtler K. Spahn L. Koseki H. Jenuwein T. Wutz A. Recruitment of PRC1 function at the initiation of X inactivation independent of PRC2 and silencing. Embo J. 2006;25:3110–3122. PubMed PMC

Nora EP. Heard E. X chromosome inactivation: when dosage counts. Cell. 2009;139:865–867. PubMed

Okamura D. Tokitake Y. Niwa H. Matsui Y. Requirement of Oct3/4 function for germ cell specification. Dev Biol. 2008;317:576–584. PubMed

Silva J. Smith A. Capturing pluripotency. Cell. 2008;132:532–536. PubMed PMC

Jirmanova L. Afanassieff M. Gobert-Gosse S. Markossian S. Savatier P. Differential contributions of ERK and PI3-kinase to the regulation of cyclin D1 expression and to the control of the G1/S transition in mouse embryonic stem cells. Oncogene. 2002;21:5515–5528. PubMed

Burdon T. Smith A. Savatier P. Signalling, cell cycle and pluripotency in embryonic stem cells. Trends Cell Biol. 2002;12:432–438. PubMed

Tavakoli T. Xu X. Derby E. Serebryakova Y. Reid Y. Rao MS. Mattson MP. Ma W. Self-renewal and differentiation capabilities are variable between human embryonic stem cell lines I3, I6 and BG01V. BMC Cell Biol. 2009;10:44. PubMed PMC

Allegrucci C. Young LE. Differences between human embryonic stem cell lines. Hum Reprod Update. 2007;13:103–120. PubMed

Bártová E. Pacherník J. Kozubík A. Kozubek S. Differentiation-specific association of HP1alpha and HP1beta with chromocentres is correlated with clustering of TIF1beta at these sites. Histochem Cell Biol. 2007;127:375–388. PubMed

Niwa H. Miyazaki J. Smith AG. Quantitative expression of Oct-3/4 defines differentiation, dedifferentiation or self-renewal of ES cells. Nat Genet. 2000;24:372–376. PubMed

Constantinescu D. Gray HL. Sammak PJ. Schatten GP. Csoka AB. Lamin A/C expression is a marker of mouse and human embryonic stem cell differentiation. Stem Cells. 2006;24:177–185. Erratum in: 474. PubMed

Nichols J. Zevnik B. Anastassiadis K. Niwa H. Klewe-Nebenius D. Chambers I. Schöler H. Smith A. Formation of pluripotent stem cells in the mammalian embryo depends on the POU transcription factor Oct4. Cell. 1998;95:379–391. PubMed

Chambers I. Colby D. Robertson M. Nichols J. Lee S. Tweedie S. Smith A. Functional expression cloning of Nanog, a pluripotency sustaining factor in embryonic stem cells. Cell. 2003;113:643–655. PubMed

Mitsui K. Tokuzawa Y. Itoh H. Segawa K. Murakami M. Takahashi K. Maruyama M. Maeda M. Yamanaka S. The homeoprotein Nanog is required for maintenance of pluripotency in mouse epiblast and ES cells. Cell. 2003;113:631–642. PubMed

Graf T. Stadtfeld M. Heterogeneity of embryonic and adult stem cells. Cell Stem Cell. 2008;3:480–483. PubMed

Levsky JM. Shenoy SM. Pezo RC. Singer RH. Single-cell gene expression profiling. Science. 2002;297:836–840. PubMed

Wilson AJ. Velcich A. Arango D. Kurland AR. Shenoy SM. Pezo RC. Levsky JM. Singer RH. Augenlicht LH. Novel detection and differential utilization of a c-myc transcriptional block in colon cancer chemoprevention. Cancer Res. 2002;62:6006–6010. PubMed

Osborne CS. Chakalova L. Brown KE. Carter D. Horton A. Debrand E. Goyenechea B. Mitchell JA. Lopes S. Reik W. Fraser P. Active genes dynamically colocalize to shared sites of ongoing transcription. Nat Genet. 2004;36:1065–1071. PubMed

Hoffman LM. Hall L. Batten JL. Young H. Pardasani D. Baetge EE. Lawrence J. Carpenter MK. X-inactivation status varies in human embryonic stem cell lines. Stem Cells. 2005;23:1468–1478. PubMed

Caillier M. Thénot S. Tribollet V. Birot AM. Samarut J. Mey A. Role of the epigenetic regulator HP1γ in the control of embryonic stem cell properties. PLoS One. 2010;5:e15507. PubMed PMC

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...